ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
British specialty chemicals company Yule Catto is selling its James Robinson subsidiary to India's Vivimed Labs, a maker of pharmaceutical and personal care ingredients, for roughly $25.7 million. James Robinson develops photographic and photochromic chemicals, and hair and other dyes. In 2006, it had sales of about $35 million and an operating profit of $1.6 million. The acquisition, Vivimed Managing Director Santosh Varalwar says, is in line with his firm's goal of "achieving a leadership position in the global personal care actives industry."
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter